Abstract
Plasma immunoreactive beta-melanocyte stimulating hormone (beta-MSH) concentrations were greatly increased in patients with chronic renal failure. There was no correlation between the severity of the renal failure or the degree of pigmentation and the plasma beta-MSH levels.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abe K., Nicholson W. E., Liddle G. W., Island D. P., Orth D. N. Radioimmunoassay of beta-MSH in human plasma and tissues. J Clin Invest. 1967 Oct;46(10):1609–1616. doi: 10.1172/JCI105653. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Abe K., Nicholson W. E., Liddle G. W., Orth D. N., Island D. P. Normal and abnormal regulation of beta-msh in man. J Clin Invest. 1969 Aug;48(8):1580–1585. doi: 10.1172/JCI106123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bloomfield G. A., Scott A. P., Lowry P. J., Gilkes J. J., Rees L. H. A reappraisal of human beta MSH. Nature. 1974 Dec 6;252(5483):492–493. doi: 10.1038/252492a0. [DOI] [PubMed] [Google Scholar]
- Thody A. J., Plummer N. A. A radioimmunoassay for beta-melanocyte-stimulating hormone in human plasma. J Endocrinol. 1973 Aug;58(2):263–273. [PubMed] [Google Scholar]